Beamtree Holdings Ltd · ASX:BMT
Beamtree — Shareholder Meeting (October 2021)
22 slides from Beamtree's shareholder meeting presentation, Oct 28, 2021
Slide 1: 2021 Annual General Meeting
personal use only 2021 Annual General Meeting 28 October 2021 Better has no limit
Slide 2: Board of Directors
Board of Directors personal use only Mike Hill James Birch Stephen Borness Chairman of the Board Non-Executive Director Non-Executive Director Andrew Gray Brad Lancken Paul Williams Non-Executive Director Non-Executive Director Non-Executive Director Copyright © Beamtree Holdings Limited – All Right
Slide 3: AGM Agenda
AGM Agenda personal use only Chair’s Address 1 • FY21 Highlights Management Update • Potential(x) Acquisition / Integration • 1Q FY22 business update 2 Order of business • Resolutions 3 Q&A 4 Copyright © Beamtree Holdings Limited – All Rights Reserved 2
Slide 4: Beamtree enjoyed a record year in FY21 and completed major acquisitions
Beamtree enjoyed a record year in FY21 and completed major acquisitions personal use only We have won major contracts in Australia and internationally Retention and renewals reached record rates in FY21 Ai Key acquisition of Ainsoff to drive AI product innovation We’re growing with a new name, new p
Slide 5: Record Growth and Global Impact FY21
Record Growth and Global Impact FY21 personal use only 50.4m+ people touched by Beamtree implementations every year Beamtree is a proud Australian company supporting customers globally 1000+ 155+ 705+ 4 22 140+ Hospitals Labs Hospitals Continents Countries Customers
Slide 6: Highlights of a strong year of growth
Highlights of a strong year of growth July January May September personal use only New agreement with SA $2.5m renewal agreement St Vincent’s Health Australia Finalised the acquisition of Pathology with Philips reveals 16% reduction in Potential(x). hospital acquired complications Global HQ opens in
Slide 7: Growth strategy delivers at home and internationally
Growth strategy delivers at home and internationally personal use only Winning customers Major new client wins for PICQ® (data quality) and RISQTM (benchmarking services) in Australian hospitals. These services now assess around 90% of inpatient activity in Australia. International expansion Winning
Slide 8: Financial Summary FY21
Financial Summary FY21 Strong total revenue Continued annualised recurring personal use only performance $8.9 million revenue growth YoY Exceeded management $3.1 million forecast Strong cash position and Globally zero debt *Pavilion Health was acquired in May 2020. 2020 pro-forma represents the comb
Slide 9: Business Overview
Successfully completed the acquisition of Business Overview personal use only There’s too much data, How are we performing Who is performing best, How can we implement how do I get meaningful relative to peers? and what can I learn? and sustain? information to improve? End User Go to market Collabor
Slide 10: FY21 pro-forma P&L
FY21 pro-forma P&L + personal use only ($,000) Pro-forma FY21A FY21A FY21PF Commentary Recurring – Software Subscription & Licenses 6,138 1,061 7,199 • The acquisition of Potential(x) Recurring – Data Analytics Platform - 8,591 8,591 significantly increases Beamtree’s scale Recurring – Service 448 -
Slide 11: FY21 pro-forma revenue composition
FY21 pro-forma revenue composition personal use only Pro-forma 8% 14% Legend 21% Recurring - subscriptions, licenses and services Non-Recurring - consultancy and $6.7m $9.5m $16.2m advisory ARR ARR ARR 79% 86% 92% Commentary The acquisition of Potential(x) will increase Beamtree’s recurring revenue
Slide 12: Beamtree and Potential(x) Integration
Beamtree and Potential(x) Integration Over the next few months, the Beamtree and Potential(x) teams will personal use only continue to work on the post-merger integration. The strategic objectives of the merger are to: • Accelerate growth in new global markets and adjacent sectors • Add value and ma
Slide 13: Beamtree and Potential(x) Integration
Beamtree and Potential(x) Integration We have identified seven post merger integration guiding principles personal use only Customers who positively experience our service and innovations – so they advocate our brand 1 Value Creation – through appropriate focus on strategy, governance, risk, revenue
Slide 14: Successfully completed the acquisition of Ainsoff
Successfully completed the acquisition of Ainsoff personal use only Artificial intelligence supporting Clinical trial outcomes clinical decision support The first of our clinical decision support tools performed better than existing early warning systems. It demonstrated greater specificity and sign
Slide 15: Successful acquisitions drive Beamtree's future growth
Successful acquisitions drive Beamtree’s future growth personal use only Domestic $100m, Domestic $310m, Domestic $427m, International $3.8bn International $10.1bn International $13.6bn Partnering globally, shared expansion footprint | Coalesce and scale technical expertise for new products Pillar 1
Slide 16: Implementing the growth strategy
Implementing the growth strategy personal use only Automation of Global Building research success and 15
Slide 17: How we create value
How we create value Driving continuous improvement by better access to healthcare information – towards The Learning Health System safety, quality and efficiency. personal use only Return knowledge to Collect health the rules engine information Support clinicians Encode in standard coders and format
Slide 18: Transforming knowledge management in healthcare
Transforming knowledge management in healthcare personal use only The integrated platform builds on world-class The Beamtree knowledge management platform core products for information and knowledge management. It empowers a learning health Computer coding of clinical records, automation of system,
Slide 19: 1Q FY22 Trading Updates
1Q FY22 Trading Updates personal use only Key new contracts including major strategic partnerships with Southern Health DHB in New Zealand to implement proprietary data capture bar coding technology to support quality surveillance of outcomes in allied health, and a strategic partnership with Centra
Slide 20: Beamtree Global Impact Committee
Beamtree Global Impact Committee The GIC is an advisory board that will provide advice on strategies and policies, promote best practice and innovation in health data, and personal use only advance the Beamtree mission to mobilise the power of data for a healthier, happier world. The GIC will lead t
Slide 21: Beamtree Global Impact Committee
Beamtree Global Impact Committee Dr. Mark Britnell (Chair UK) Prof. Low Cheng Ooi (Singapore) International health reform expert who has served governments in more CTO Sheares Healthcare ; former Chief Medical Information Officer, Ministry personal use only than 80 countries of Health, Singapore Jam
Slide 22: Thank you for your attendance
personal use only Thank you for your attendance Better has no limit
Beamtree Holdings — Shareholder Meeting (October 2021) on 6ix